ClinicalTrials.gg
RecruitingNCT06530264Updated Jul 31, 2024

Evaluation of Different Methods of Posterior Flap Management in External Dacryocystorhinostomy

An interventional study of DCR in Acquired Nasolacrimal Duct Obstruction, sponsored by Minia University. Recruiting at 1 site in Egypt. Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2024-07-31.

Sponsored by Minia University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Oct 2024, 2 years 1 month ago, but the record still lists the study as recruiting.
  • Registered 1 year 9 months after the study started (first participant enrolled Oct 2022, registered Jul 2024).
  • Started Oct 2022; still recruiting 4 years later.
Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Not applicable
Ages
18 Years to 75 Years
Sex
All
01

Study summary

The aim of DCR is to form a new, mucosa-lined pathway between the lacrimal sac and the nasal cavity where tears can bypass a lacrimal obstruction and drain directly in the nose. The original external approach was described in 19046. In 1920s, mucosal flap anastomosis was added to the procedure as a modification7, and since then, many new modifications have been made to improve the original procedure.

Read the detailed description

Aim of The Study

  • To compare intraoperative details and postoperative endonasal endoscopic findings and their effects on success rate of external dacryocystorhinostomy with and without anastomosis of posterior mucosal flaps.

Patients and Methods

Study Design: This will be a prospective interventional comparative clinical study. It will include two groups according to the surgical procedure:- Group A: includes 30 eyes that will be treated with external DCR with anastomosis of posterior mucosal flaps .

Group B: includes 30 eyes that will be treated with external DCR with amputation of posterior mucosal flaps .

Study Population:

Study participants will be: 60 eyes undergo external DCR . All patients included in this study will be verbally briefed about the details and the nature of the study \& will sign a written consent according to the local Ethics Committee of Minia University Faculty of Medicine. The study will be conducted in Ophthalmology department, Minia university Hospital, Egypt.

02

Conditions studied

  • Acquired Nasolacrimal Duct Obstruction

Keywords

  • Posterior flap
  • DCR
  • NLDO
03

In context

Lacrimal Duct Obstruction

41 studies on the registry are indexed under Lacrimal Duct Obstruction; 8 are open to participants now.

This study's planned enrollment of 100 is above the median of 75 across 30 interventional studies indexed under Lacrimal Duct Obstruction.

Browse Lacrimal Duct Obstruction studies →

Lead sponsor

Minia University is the lead sponsor of 370 studies on the registry; 117 are open to participants now.

Of its 6 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients with chronic dacryocystits,
  • primary nasolacrimal duct obstruction
  • Lacrimal mucocele
  • Lacrimal fistula

Exclusion criteria

Exclusion Criteria:

  • Recurrent cases.
  • Age under 5 years.
  • Associated nasal pathology.
  • Sever dry eye
  • Patients unfit for general anaesthesia
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Sequential assignment
Masking
None (open label)
Enrollment
100 participants (estimated)

Study arms

  • Other
    External DCR

    Different techniques in posterior flap management

    Other: DCR

Interventions

  • OtherDCR

    6. An H shaped incision at the postero-inferior lacrimal sac is made, with a long anterior flap and shorter posterior flap. Similarly an H shaped incision at the nasal mucosa is made. The posterior flap of lacrimal sac is sutured with posterior flap of nasal mucosa in interrupted fashion using 6-0 vicryl sutures in Group A, while in Group B the posterior flap is trimmed without suturing.

    Also known as: posterior flap management

06

What researchers measure

Primary outcomes

  1. Management of posterior flap in external DCR

    Evaluation of different methods of posterior flaps management in external dacryocystorhinostomy using nasal endoscopy for evaluation of outcomes

    Time frame: patient evaluated at 2 months after surgery then at 4th month then 6th month

07

Study locations

1 of 1 sites recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Oct 2022 (actual). Primary completion is estimated for Oct 2024, 23 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 19, 2024
First posted
Jul 31, 2024
StartActual
Oct 15, 2022
Primary completionEst.
Oct 10, 2024
CompletionEst.
Oct 15, 2024
Last update
Jul 31, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 31, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06530264
Lead sponsor
Minia University
Responsible party
Mohammed Sayed Abdelmaaboud Abdelmoneem (Mohammed Sayed Abdelmaaboud, Minia University) — Principal investigator
First posted
Jul 31, 2024
Start date
Oct 15, 2022
Primary completion
Oct 10, 2024 (estimated)
Completion
Oct 15, 2024 (estimated)
Last update
Jul 31, 2024

Study contacts

Mohammed Sayed Abdelmaaboud, MD
Contact
oph.msa1990@gmail.com
01092503977 ext. +20
Mohamed Farouk Sayed, Prof
Contact
mohamed.osman@mu.edu.eg
01062555738 ext. +20

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion